| Literature DB >> 27374498 |
Vicky Lampropoulou1, Alexey Sergushichev2, Monika Bambouskova1, Sharmila Nair3, Emma E Vincent4, Ekaterina Loginicheva1, Luisa Cervantes-Barragan1, Xiucui Ma5, Stanley Ching-Cheng Huang1, Takla Griss4, Carla J Weinheimer6, Shabaana Khader7, Gwendalyn J Randolph1, Edward J Pearce8, Russell G Jones4, Abhinav Diwan5, Michael S Diamond9, Maxim N Artyomov10.
Abstract
Remodeling of the tricarboxylic acid (TCA) cycle is a metabolic adaptation accompanying inflammatory macrophage activation. During this process, endogenous metabolites can adopt regulatory roles that govern specific aspects of inflammatory response, as recently shown for succinate, which regulates the pro-inflammatory IL-1β-HIF-1α axis. Itaconate is one of the most highly induced metabolites in activated macrophages, yet its functional significance remains unknown. Here, we show that itaconate modulates macrophage metabolism and effector functions by inhibiting succinate dehydrogenase-mediated oxidation of succinate. Through this action, itaconate exerts anti-inflammatory effects when administered in vitro and in vivo during macrophage activation and ischemia-reperfusion injury. Using newly generated Irg1(-/-) mice, which lack the ability to produce itaconate, we show that endogenous itaconate regulates succinate levels and function, mitochondrial respiration, and inflammatory cytokine production during macrophage activation. These studies highlight itaconate as a major physiological regulator of the global metabolic rewiring and effector functions of inflammatory macrophages.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27374498 PMCID: PMC5108454 DOI: 10.1016/j.cmet.2016.06.004
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287